More than 50,000 bone marrow-derived stem cell transplants are performed worldwide each year to treat a wide range of conditions, including brain diseases. Before the cells are transplanted, the patients are given chemotherapy ...
Feb 21, 2022
0
59
A team of researchers at the New York-Presbyterian/Weill Cornell Medical Center announced that a woman they have been treating for both HIV and leukemia has apparently been cured of HIV—14 months after discontinuing antivirals, ...
Over the past three decades, efforts to improve the results of standard treatment for patients with severe aplastic anemia have been largely unsuccessful. The phase III RACE trial, sponsored by the European Society for Blood ...
Jan 5, 2022
0
46
(HealthDay)—If you're a patient with a weakened immune system, roll up your sleeves to stay safe over the holidays and winter months.
Dec 6, 2021
0
3
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all ...
Dec 1, 2021
0
1
Two years ago Laetitia Defoi suffered serious health complications from a blood transfusion gone wrong.
Nov 17, 2021
0
1
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Oct 20, 2021
0
6
New research from Roswell Park Comprehensive Cancer Center has uncovered genetic factors other than human leukocyte antigen (HLA) compatibility that significantly contribute to outcomes following blood and marrow transplant ...
Oct 18, 2021
0
9
(HealthDay)—Allogeneic blood or marrow transplantation (BMT) recipients have experienced a reduction in late mortality over time, according to a study published online Sept. 9 in JAMA Oncology.
Sep 14, 2021
0
4
French pharmaceutical giant Sanofi announced on Wednesday its second acquisition of a US firm in as many months, buying transplant drug company Kadmon for $1.9 billion (1.6 billion euros).
Sep 8, 2021
0
3
